PTC Therapeutics Inc logo

PTC Therapeutics Inc

NAS:PTCT (USA)   Ordinary Shares
$ 25.32 +0.63 (+2.55%) 10:08 PM EST
At Loss
Volume:
2.31M
Avg Vol (2M):
791.70K
Also Trade In:
Volume:
2.31M
At Loss
Avg Vol (2M):
791.70K

Business Description

PTC Therapeutics Inc logo
PTC Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US69366J2006

Share Class Description:

PTCT: Ordinary Shares
Description
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 0.39
Equity-to-Asset -0.43
Debt-to-Equity -2.72
Debt-to-EBITDA -6.75
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.11
Distress
Grey
Safe
Beneish M-Score -3.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.08
9-Day RSI 35.15
14-Day RSI 38.17
6-1 Month Momentum % 29.1
12-1 Month Momentum % -42.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.02
Quick Ratio 1.97
Cash Ratio 1.45
Days Inventory 163.65
Days Sales Outstanding 67.06
Days Payable 116.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.8
Shareholder Yield % -17.56

Financials (Next Earnings Date:2024-04-25)

PTCT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PTCT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PTC Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 937.822
EPS (TTM) ($) -8.36
Beta 0.61
Volatility % 64.93
14-Day RSI 38.17
14-Day ATR ($) 1.353593
20-Day SMA ($) 27.3315
12-1 Month Momentum % -42.8
52-Week Range ($) 17.53 - 59.84
Shares Outstanding (Mil) 76.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PTC Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

PTC Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

PTC Therapeutics Inc Frequently Asked Questions

What is PTC Therapeutics Inc(PTCT)'s stock price today?
The current price of PTCT is $25.32. The 52 week high of PTCT is $59.84 and 52 week low is $17.53.
When is next earnings date of PTC Therapeutics Inc(PTCT)?
The next earnings date of PTC Therapeutics Inc(PTCT) is 2024-04-25.
Does PTC Therapeutics Inc(PTCT) pay dividends? If so, how much?
PTC Therapeutics Inc(PTCT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1